Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-13

FDA Approved: ALLERGY RELIEF — Supplemental Application (WALGREENS)

View source ↗

Summary

FDA approves Walgreens' supplemental application for an allergy-relief product containing cetirizine hydrochloride (Allergy Relief).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

SUPPL AP for ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE)